Provides medically monitored detox services for individuals suffering from acute substance use disorder, primarily from alcohol or opioids, through Gallus Medical Detox Centers.

Evaluates and invests in smaller private companies or micro-cap public entities with revenues of $2 to $25 million and positive cash flow, focusing on sectors with manageable competitive dynamics.